Study Identifies NK Cells as Potential Therapy for Solid Tumors

A preclinical study conducted by Stanford Medicine has demonstrated that tissue-resident natural killer (NK) cells effectively inhibited solid tumor growth in mouse models. These specialized cytotoxic NK cells, derived from donor blood, exhibited superior infiltration into tumors compared to conventional NK cells. This finding suggests a promising avenue for developing an accessible 'off-the-shelf' cell therapy for various solid tumors.